Publicacións en colaboración con investigadores/as de University of British Columbia (29)

2025

  1. Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial

    Journal of Hepatology

  2. Validating the Hierarchical Nature of the AO Spine Upper Cervical Spine Injury Classification System

    Spine

2024

  1. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  2. Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. e013743

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. An international validation of the AO spine subaxial injury classification system

    European Spine Journal, Vol. 32, Núm. 1, pp. 46-54

  3. Care transitions among oncological patients: from hospital to community

    Revista da Escola de Enfermagem da U S P, Vol. 56, pp. e20220308

2022

  1. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    JHEP Reports, Vol. 4, Núm. 5

  2. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

  3. European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones

    European Urology Focus, Vol. 8, Núm. 5, pp. 1461-1468

  4. Monoamine neurotransmitters in early epileptic encephalopathies: New insights into pathophysiology and therapy

    Developmental Medicine and Child Neurology, Vol. 64, Núm. 7, pp. 915-923

  5. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

    The Lancet Oncology, Vol. 23, Núm. 3, pp. 362-373

  6. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  7. RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

    Frontiers in immunology, Vol. 13, pp. 880368

  8. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper

    Frontiers in Immunology, Vol. 12

  2. Outcomes of Participants With Diabetes in the ISCHEMIA Trials

    Circulation, Vol. 144, Núm. 17, pp. 1380-1395

  3. Resuscitation and emergency care in drowning: A scoping review

    Resuscitation, Vol. 162, pp. 205-217

  4. Treatment of Multisystem Inflammatory Syndrome in Children

    New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22

2020

  1. A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective

    Patient, Vol. 13, Núm. 3, pp. 317-325